MDPI and ACS Style
Schuit, A.S.; Holtmaat, K.; Coupé, V.M.H.; Eerenstein, S.E.J.; Zijlstra, J.M.; Eeltink, C.; Becker-Commissaris, A.; van Zuylen, L.; van Linde, M.E.; Menke-van der Houven van Oordt, C.W.;
et al. Cost-Utility of the eHealth Application ‘Oncokompas’, Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial. Curr. Oncol. 2022, 29, 6186-6202.
https://doi.org/10.3390/curroncol29090486
AMA Style
Schuit AS, Holtmaat K, Coupé VMH, Eerenstein SEJ, Zijlstra JM, Eeltink C, Becker-Commissaris A, van Zuylen L, van Linde ME, Menke-van der Houven van Oordt CW,
et al. Cost-Utility of the eHealth Application ‘Oncokompas’, Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial. Current Oncology. 2022; 29(9):6186-6202.
https://doi.org/10.3390/curroncol29090486
Chicago/Turabian Style
Schuit, Anouk S., Karen Holtmaat, Veerle M. H. Coupé, Simone E. J. Eerenstein, Josée M. Zijlstra, Corien Eeltink, Annemarie Becker-Commissaris, Lia van Zuylen, Myra E. van Linde, C. Willemien Menke-van der Houven van Oordt,
and et al. 2022. "Cost-Utility of the eHealth Application ‘Oncokompas’, Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial" Current Oncology 29, no. 9: 6186-6202.
https://doi.org/10.3390/curroncol29090486